Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Marimed (MRMD) Current Assets (2016 - 2025)

Marimed has reported Current Assets over the past 15 years, most recently at $59.3 million for Q4 2025.

  • Quarterly Current Assets rose 10.8% to $59.3 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $59.3 million through Dec 2025, up 10.8% year-over-year, with the annual reading at $59.3 million for FY2025, 10.8% up from the prior year.
  • Current Assets was $59.3 million for Q4 2025 at Marimed, down from $60.1 million in the prior quarter.
  • Over five years, Current Assets peaked at $60.1 million in Q3 2025 and troughed at $31.7 million in Q1 2021.
  • The 5-year median for Current Assets is $53.3 million (2024), against an average of $50.5 million.
  • Year-over-year, Current Assets skyrocketed 215.07% in 2021 and then fell 17.88% in 2022.
  • A 5-year view of Current Assets shows it stood at $44.6 million in 2021, then dropped by 1.05% to $44.1 million in 2022, then grew by 16.5% to $51.4 million in 2023, then grew by 4.04% to $53.5 million in 2024, then increased by 10.8% to $59.3 million in 2025.
  • Per Business Quant, the three most recent readings for MRMD's Current Assets are $59.3 million (Q4 2025), $60.1 million (Q3 2025), and $57.1 million (Q2 2025).